Market Overview

Benzinga's Top Pre-Market Gainers

Share:
Related LXRX
Buy/High Risk Rating Given To Lexicon Pharmaceuticals By Citi Analysts
Every Biotech Catalyst Wedbush Is Watching In 2016
Related TEVA
Drug Price Hike Concerns Spill Over Into Other Pharma Stocks
Have You Heard About This Generic EpiPen Maker?
A Comprehensive Look at Dividend Growth Stock Valuations Sector by Sector: Part — (GuruFocus)

Lexicon Pharmaceuticals (NASDAQ: LXRX) surged 21.99% to $2.33 in the pre-market session. Lexicon Pharmaceuticals reported positive results of LX4211 Phase 2b trial for type 2 diabetes.

Teva Pharmaceutical Industries Limited (NASDAQ: TEVA) added 6.87% to $40.62 in the pre-market session. Teva reported favorable court ruling in COPAXONE® patent infringement litigation.

Watson Pharmaceuticals (NYSE: WPI) moved up 2.37% to $72.70 in the pre-market session. Watson Pharmaceuticals entered into a new senior secured term loan facility in an aggregate principal amount of $1.8 billion..

SanDisk (NASDAQ: SNDK) soared 1.35% to $36.85 in the pre-market trading. Analysts at Goldman Sachs upgraded SanDisk from “neutral” to “buy.”

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (LXRX + SNDK)

View Comments and Join the Discussion!